表紙:ゲノミクスの世界市場 - 産業規模、シェア、動向、機会、予測:製品・サービス別、技術別、用途別、エンドユーザー別、企業別、地域別(2017年~2027年)
市場調査レポート
商品コード
1152248

ゲノミクスの世界市場 - 産業規模、シェア、動向、機会、予測:製品・サービス別、技術別、用途別、エンドユーザー別、企業別、地域別(2017年~2027年)

Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Products & Services, By Technology, By Application, By End User, By Company, and By Region

出版日: | 発行: TechSci Research | ページ情報: 英文 117 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

ゲノミクスの世界市場 - 産業規模、シェア、動向、機会、予測:製品・サービス別、技術別、用途別、エンドユーザー別、企業別、地域別(2017年~2027年)
出版日: 2022年11月01日
発行: TechSci Research
ページ情報: 英文 117 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のゲノミクス市場は、予測期間中の2023年~2027年に目覚ましい成長を遂げると予測されています。

成長の主要な要因として、特殊な医薬品の増加、様々な分野でのゲノミクスの幅広い応用などが挙げられます。

現在、遺伝性疾患や慢性疾患を患っていると診断された人々のため、個別化医療に対する需要が急増しており、それが市場成長を後押ししています。また、診断技術の進歩、政府による投資拡大、がん罹患率の上昇、研究開発イニシアチブの活発化なども、市場成長を支える要因となっています。

当レポートでは、世界のゲノミクス市場について調査分析し、セグメント別・地域別の市場規模・シェア予測、市場力学、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 製品概要

第2章 調査手法

第3章 世界ゲノミクス市場に対するCOVID-19の影響

第4章 VOC(顧客の声)

第5章 エグゼクティブサマリー

第6章 世界のゲノミクス市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品・サービス別(システムとソフトウェア、消耗品、サービス)
    • 技術別(シーケンシング、PCR、核酸抽出・精製、マイクロアレイ、その他)
    • 用途別(創薬・開発、診断、農業・動物研究、その他)
    • エンドユーザー別(病院・クリニック、学術・研究機関、バイオテクノロジー・製薬会社、その他)
    • 企業別(2021年)
    • 地域別
  • 市場マップ

第7章 北米のゲノミクス市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品・サービス別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第8章 欧州のゲノミクス市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品・サービス別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋のゲノミクス市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品・サービス別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋:国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米のゲノミクス市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品・サービス別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカのゲノミクス市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品・サービス別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 国別
  • MEA:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • エジプト
    • トルコ

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と開発

第14章 競合情勢

  • Illumina, Inc.
  • Thermo Fischer Scientific, Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific SE
  • Oxford Nanopore Technologies Limited
  • Pacific Biosciences of California, Inc.
  • Danaher Corporation
  • GE Healthcare
  • Myriad Genetics, Inc.
  • 23andMe, Inc.
  • Eppendorf AG
  • Quest Diagnostics Inc.

第15章 戦略的提言

目次
Product Code: 12987

The global genomics market is anticipated to observe an impressive growth during the forecast period, 2023-2027. The major factors include growing specialized medicines and wide application of genomics in numerous areas. Genomics is the branch of science that concerned with the structure, function, evolution, and mapping of genomes. Various steps are taken such as sampling, sequencing, data analysis and interpretation procedures to decode, assemble, and analyze genomes. Nowadays, people are diagnosed with genetic as well as chronic diseases due to which demand for personalized medicine is surging, which is bolstering the growth of the market. The other factors supporting the market's growth are, advancement in diagnostic techniques, increasing investments by governments, surge in cancer incidents and rise in R&D initiatives.

Increasing Demand of Specialized/Personalized Medicine

Growing importance of specialized medicines is one of the primary factors, supporting the growth of genomics market. The ability to advance health care facilities by providing unique clinical, genetic, genomic, and environmental information is increasing the importance of genomics. Surging demand of Personalized medicines is due to their efficiency to treat unique, yet complex diseases. They help medical researchers to identify the exact requirement of patient and then treat them accordingly. Based on the 2020 Scope and Significance of Progress report, personalized medicines accounted for around 39 percent of the total FDA-approved new drugs in the year. Doctors, researchers, and pharmaceutical firms are using precision medicine for developing new drug and disease therapies, and unique clinical testing. Personalized medicine uses all genes in human genome for identification, prevention, and treatment of any complex disease.

Growing Application of Genomics in Various Sectors.

The use of genomics concepts in the field of synthetic biology, healthcare, study gene sequences of plants and organisms, and bioengineering sectors are some of the applications, which is anticipating the growth of the market. For instance, agricultural genomics is a field that is contributing to advances in crop development such as it can lessen the trials and failures involved in scientific research to a certain extent, which could enhance the quality and quantity of crop yields in agriculture. In December 2020, Calyxt, Inc. announced signing a research collaboration with NRGene Ltd. that comprises the use of the cloud-based genomic platform of NRGene to fast-track hemp trait discovery.

Technological Advancements

Rapid advancements and innovations in the genomics sector are bolstering the growth of the market. The advent of cheaper nucleic acid sequencing is modifying DNA and RNA on demand. Sensing the increasing demand several companies are offering sequencing services for nutrition, ancestry, and genetic diseases. Rapid advances in microscopy are also in process. For instance, in 2019, Thermo Fisher Scientific, Inc. (US) introduced the Oncomine Precision Assay, an innovative pan-cancer panel, for its Genexus platform to advance precision medicine in clinical settings. Other factors, such as massive research and development (R&D) activities in the bioinformatics sector and the increasing demand for next-generation sequencing services, are anticipating the growth of the market.

Market Segmentation

The global genomics market is segmented into products & services, technology, application, end user, and company. Based on products & services, the market is divided into systems & software, consumables, and service. Based on technology, the market is divided into sequencing, PCR, nucleic acid extraction and purification, microarray, and others. Based on application, the market is segmented into drug discovery & development, diagnostics, agriculture & animal research, and others. Based on end user, the market is divided into hospitals & clinics, academic & research institutions, biotechnology & pharmaceutical companies, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising importance of personalized medicines and wide application of genomics in the country.

Market Players

Illumina, Inc., Thermo Fischer Scientific, Inc., QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Eurofins Scientific SE, Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., Danaher Corporation, GE Healthcare, Myriad Genetics, Inc., 23andMe, Inc., Eppendorf AG, and Quest Diagnostics Inc. are some of the leading companies operating in the market.

Report Scope:

In this report, global genomics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Genomics Market, By Products & Services:

  • Systems & Software
  • Consumables
  • Service

Genomics Market, By Technology:

  • Sequencing
  • PCR
  • Nucleic Acid Extraction and Purification
  • Microarray
  • Others

Genomics Market, By Application:

  • Drug Discovery & Development
  • Diagnostics
  • Agriculture & Animal Research
  • Others

Genomics Market, By Application:

  • Hospitals & Clinics
  • Academic & Research Institutions
  • Biotechnology & Pharmaceutical Companies
  • Others

Genomics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Genomics Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Genomics Market

4. Voice of Customer

5. Executive Summary

6. Global Genomics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products & Services (Systems & Software, Consumables, Service)
    • 6.2.2. By Technology (Sequencing, PCR, Nucleic Acid Extraction and Purification, Microarray, Others)
    • 6.2.3. By Application (Drug Discovery & Development, Diagnostics, Agriculture & Animal Research, Others)
    • 6.2.4. By End User (Hospitals & Clinics, Academic & Research Institutions, Biotechnology & Pharmaceutical Companies, Others)
    • 6.2.5. By Company (2021)
    • 6.2.6. By Region
  • 6.3. Market Map

7. North America Genomics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products & Services
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Genomics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product & Services
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Mexico Genomics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product & Services
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Canada Genomics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product & Services
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Genomics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products & Services
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Genomics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product & Services
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Genomics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product & Services
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Genomics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product & Services
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Genomics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product & Services
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Genomics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product & Services
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Genomics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products & Services
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Genomics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product & Services
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. India Genomics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product & Services
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Japan Genomics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product & Services
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Genomics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product & Services
        • 9.3.4.2.2. By Technology
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Genomics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product & Services
        • 9.3.5.2.2. By Technology
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Genomics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products & Services
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Genomics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product & Services
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Genomics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product & Services
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Genomics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product & Services
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Genomics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Products & Services
    • 11.2.2. By Technology
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Genomics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product & Services
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Genomics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product & Services
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Genomics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product & Services
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User
    • 11.3.4. Egypt Genomics Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product & Services
        • 11.3.4.2.2. By Technology
        • 11.3.4.2.3. By Application
        • 11.3.4.2.4. By End User
    • 11.3.5. Turkey Genomics Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Product & Services
        • 11.3.5.2.2. By Technology
        • 11.3.5.2.3. By Application
        • 11.3.5.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Illumina, Inc.
  • 14.2. Thermo Fischer Scientific, Inc.
  • 14.3. QIAGEN N.V.
  • 14.4. Agilent Technologies, Inc.
  • 14.5. F. Hoffmann-La Roche AG
  • 14.6. Bio-Rad Laboratories, Inc.
  • 14.7. Eurofins Scientific SE
  • 14.8. Oxford Nanopore Technologies Limited
  • 14.9. Pacific Biosciences of California, Inc.
  • 14.10. Danaher Corporation
  • 14.11. GE Healthcare
  • 14.12. Myriad Genetics, Inc.
  • 14.13. 23andMe, Inc.
  • 14.14. Eppendorf AG
  • 14.15. Quest Diagnostics Inc.

15. Strategic Recommendations